Why Is USFDA Inspecting India Pharma Firms?

Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com   The Indian pharmaceutical industry's recent tryst with the US drug regulator......

Why China won't attend NSA-level meet on Afghanistan hosted by India

China said on Tuesday that it is not attending the security dialogue on Afghanistan convened by India due to "scheduling reasons". IMAGE: A week before the Taliban captured Kabul, Chinese Foreign......

How to DEFEAT the NEXT Pandemic

Illustrious international thinkers met at the Milken Institute Global Conference 2021 to address the impact of the COVID-19 pandemic on the world at large and the accompanying economic......

'We put pressure on Biden admn over vaccines'

'Supplies should start moving to the Serum Institute without any impediments.' IMAGE: Oxygen concentrators sent by the US-India Strategic Partnership Forum arrive in New Delhi. Photograph: Mukesh......

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

Pharma funds: 'Enter with a horizon of 5-7 years or more'

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. Photograph: Yves......

3 sectors to watch for as economic growth picks up

Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22, says Subodh Rai. Telcos will push to raise......

Why investors are regretting giving Gland Pharma IPO a miss

Gland Pharma, promoted by China's Fosun, has extended its gains, is up 40 per cent since its listing. Illustration: Uttam Ghosh/Rediff.com Retail and high-networth individuals (HNIs) would be......